These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2283041)
61. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Fisher DJ; Fernandez-Miyakawa ME; Sayeed S; Poon R; Adams V; Rood JI; Uzal FA; McClane BA Infect Immun; 2006 Sep; 74(9):5200-10. PubMed ID: 16926413 [TBL] [Abstract][Full Text] [Related]
62. Expression of Clostridium perfringens epsilon-beta fusion toxin gene in E. coli and its immunologic studies in mouse. Pilehchian Langroudi R; Shamsara M; Aghaiypour K Vaccine; 2013 Jul; 31(32):3295-9. PubMed ID: 23707696 [TBL] [Abstract][Full Text] [Related]
63. Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin. Cole AR; Gibert M; Popoff M; Moss DS; Titball RW; Basak AK Nat Struct Mol Biol; 2004 Aug; 11(8):797-8. PubMed ID: 15258571 [TBL] [Abstract][Full Text] [Related]
65. Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin. Payne DW; Williamson ED; Havard H; Modi N; Brown J FEMS Microbiol Lett; 1994 Feb; 116(2):161-7. PubMed ID: 7512061 [TBL] [Abstract][Full Text] [Related]
66. Ultrastructural changes in the brain of mice given Clostridium perfringens type D epsilon toxin. Finnie JW J Comp Pathol; 1984 Jul; 94(3):445-52. PubMed ID: 6088599 [TBL] [Abstract][Full Text] [Related]
67. Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon-toxin. Bhown AS; Habeerb AF Biochem Biophys Res Commun; 1977 Oct; 78(3):889-96. PubMed ID: 199192 [No Abstract] [Full Text] [Related]
68. Pharmacological effect of beta toxin of Clostridium perfringens type C on rats. Sakurai J; Fujii Y; Matsuura M; Endo K Microbiol Immunol; 1981; 25(5):423-32. PubMed ID: 6168890 [TBL] [Abstract][Full Text] [Related]
69. Evidence for cytoskeletal changes secondary to plasma membrane functional alterations in the in vitro cell response to Clostridium perfringens epsilon-toxin. Donelli G; Fiorentini C; Matarrese P; Falzano L; Cardines R; Mastrantonio P; Payne DW; Titball RW Comp Immunol Microbiol Infect Dis; 2003 May; 26(3):145-56. PubMed ID: 12581745 [TBL] [Abstract][Full Text] [Related]
70. Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis. Wagley S; Bokori-Brown M; Morcrette H; Malaspina A; D'Arcy C; Gnanapavan S; Lewis N; Popoff MR; Raciborska D; Nicholas R; Turner B; Titball RW Mult Scler; 2019 Apr; 25(5):653-660. PubMed ID: 29681209 [TBL] [Abstract][Full Text] [Related]
71. Morphological alterations in MDCK cells induced by exposure to Clostridium perfringens epsilon-toxin. Hambrook JL; Lindsay CD; Hughes N Biochem Soc Trans; 1995 Feb; 23(1):44S. PubMed ID: 7758757 [No Abstract] [Full Text] [Related]
72. [Biochemical and pharmacological studies of Clostridium perfringens epsilon-toxin]. Nagahama M Nihon Saikingaku Zasshi; 1996 Oct; 51(4):953-62. PubMed ID: 8994341 [No Abstract] [Full Text] [Related]
73. Effect of Clostridium perfringens beta toxin on blood pressure of rats. Sakurai J; Fujii Y; Dezaki K; Endo K Microbiol Immunol; 1984; 28(1):23-31. PubMed ID: 6145086 [TBL] [Abstract][Full Text] [Related]
74. Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon-toxin in the synaptosomal membrane. Miyata S; Matsushita O; Minami J; Katayama S; Shimamoto S; Okabe A J Biol Chem; 2001 Apr; 276(17):13778-83. PubMed ID: 11278924 [TBL] [Abstract][Full Text] [Related]
75. Clostridium welchii epsilon toxin in the intestinal contents of man. GLEESON-WHITE MH; BULLEN JJ Lancet; 1955 Feb; 268(6860):384-5. PubMed ID: 13234392 [No Abstract] [Full Text] [Related]
76. Selective cytotoxicity of Clostridium perfringens delta toxin on rabbit leukocytes. Jolivet-Reynaud C; Cavaillon JM; Alouf JE Infect Immun; 1982 Dec; 38(3):860-4. PubMed ID: 6295950 [TBL] [Abstract][Full Text] [Related]
77. An immunohistochemical study of plasma albumin extravasation in the brain of mice after the administration of Clostridium perfringens type D epsilon toxin. Finnie JW; Hajduk P Aust Vet J; 1992 Oct; 69(10):261-2. PubMed ID: 1445075 [No Abstract] [Full Text] [Related]
78. Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China. Liu J; Yang H; Yin Z; Jiang X; Zhong H; Qiu D; Zhu F; Li R Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):713-719. PubMed ID: 27988814 [TBL] [Abstract][Full Text] [Related]
79. High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain. Nagahama M; Sakurai J Infect Immun; 1992 Mar; 60(3):1237-40. PubMed ID: 1541539 [TBL] [Abstract][Full Text] [Related]
80. Effect of prior treatment with Clostridium perfringens epsilon toxin inactivated by various agents on lethal, pressor and contractile activities of the toxin. Nagahama M; Takahashi T; Sakurai J FEMS Microbiol Lett; 1990 Oct; 60(1-2):59-62. PubMed ID: 2283041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]